Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.

Source:http://linkedlifedata.com/resource/pubmed/id/20191477

Download in:

View as

General Info

Authors

Cimaz R, Martini G, Zulian F, Cimino L, Falcini F, Zannin ME, Alessio M, Balzarin M

Affiliation

University of Padua, Padua, Italy. zulian@pediatria.unipd.it

Abstract

To evaluate the safety and efficacy of abatacept in patients with severe juvenile idiopathic arthritis (JIA)-related uveitis refractory or intolerant to immunosuppressive and anti-tumor necrosis factor alpha (anti-TNFalpha) agents.

PMID
20191477

Publication types

Comparative Study